MRNA's earnings and revenues surpass estimates in the fourth quarter of 2024. The company reiterates 2025 total revenue guidance.

OKE's fourth-quarter earnings and revenues beat estimates. The company plans to make investments in the range of $2.8-$3.2 billion in 2025 to...

TBPH's fourth-quarter earnings match estimates while sales beat the same marginally. Increased collaboration revenues from Viatris drive revenues...

WDAY reports higher revenues year over year in the fiscal fourth quarter, backed by multiple customer wins in several end markets.

COMM reports higher revenues year over year in the fourth quarter of 2024, backed by solid demand in multiple verticals.

HOOD's fourth-quarter 2024 results surpass estimates on high net interest revenues and a surge in cryptocurrency & options trading. Yet, higher costs...

DUK's fourth-quarter 2024 earnings beat estimates, and revenues increase year over year.

Bruker delivers better-than-expected earnings and revenues in the fourth quarter of 2024.

VRSK's top line benefits from increasing revenues from the Underwriting and Rating, and Claims segments in the fourth quarter of 2024.

ALNY reports better-than-expected fourth-quarter results as both earnings and revenues beat estimates driven by higher product sales.